Published in Trans Assoc Am Physicians on January 01, 1974
Progress report. Familial inflammatory bowel disease--heredity or environment? Gut (1976) 1.81
Evidence for mycobacteria in sarcoidosis. Am J Respir Cell Mol Biol (2011) 1.17
Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax (1996) 0.98
Escherichia coli and ulcerative colitis. J R Soc Med (1997) 0.79
Hybridomas using athymic nude mouse injected with Crohn's disease (CD) tissue filtrate. Immunoreactivity of the hybridomas with CD sera. Am J Pathol (1990) 0.75
Course and prognosis of sarcoidosis around the world. Am J Med (1974) 2.41
The effect of localized injection of adjuvant material on the draining lymph node. II. Circulating lymphocytes. Immunology (1970) 2.19
A worldwide review of sarcoidosis. Ann N Y Acad Sci (1976) 2.10
Segregation of lymphocyte populations through differential migration. Nature (1969) 2.09
The effect of localized injection of adjuvant material on the draining lymph node. I. Histology. Immunology (1970) 2.00
Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96
Sarcoidosis, another disease associated with serologic evidence for herpes-like virus infection. N Engl J Med (1970) 1.78
Immunologic dysfunction in heroin addicts. Arch Intern Med (1974) 1.77
Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61
Description of sarcoidosis: Report of the Subcommittee on Classification and Definition. Ann N Y Acad Sci (1976) 1.56
Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice. Immunology (1968) 1.52
Childhood sarcoidosis--a study of 18 patients. N Engl J Med (1968) 1.51
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence. J Immunol (1972) 1.48
Sarcoidosis: clinical features and management. Med Clin North Am (1967) 1.48
Architectural organization in the interphase nucleus of the protozoan Trypanosoma brucei: location of telomeres and mini-chromosomes. EMBO J (1990) 1.44
Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg (1978) 1.44
Sarcoidosis of the pleura. Ann Intern Med (1974) 1.44
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res (1991) 1.40
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
The arthritis of sarcoidosis. Arthritis Rheum (1969) 1.36
Muscle involvement in sarcoidosis. Asymptomatic, myositis, and myopathy. Arch Neurol (1969) 1.31
Is there Kveim responsiveness in Crohn's disease? Lancet (1971) 1.26
Phytohemagglutinin skin test: a possible in vivo measure of cell-mediated immunity. J Pediatr (1972) 1.24
Effects of lymphoid depletion on the distribution of 51Cr-labeled lymph node cells in mice. Transplantation (1971) 1.23
Distribution of labeled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis. J Exp Med (1972) 1.14
Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance. Cancer Res (1987) 1.11
Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells. Cancer Res (1989) 1.09
Changes in rheumatoid factor activity during the course of sarcoidosis. Am J Med (1968) 1.09
Metastatic Crohn's disease. J Am Acad Dermatol (1984) 1.07
Lymphocyte response in sarcoidosis. Lancet (1972) 1.07
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07
Chemotherapy for advanced sarcoma: therapeutic decisions and modalities. Semin Oncol (1997) 1.06
Airway function in chronic pulmonary sarcoidosis with fibrosis. Am Rev Respir Dis (1974) 1.04
Isolation and characterization of an anthracycline-resistant human leukemic cell line. Cancer Res (1985) 1.03
Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells. Cancer Res (1989) 1.02
Assessment of potential exposure to antineoplastic agents in the health care setting. Prev Med (1984) 0.97
Qualities and behavior of satisfactory Kveim suspensions. Ann N Y Acad Sci (1976) 0.95
Tuberculin tests during the course of sarcoidosis in 350 patients. Am Rev Respir Dis (1971) 0.95
Hematologic and immunologic aspects of parabiosis. Mt Sinai J Med (1976) 0.94
Serum-migration inhibitory activity in patients with sarcoidosis. Clin Immunol Immunopathol (1979) 0.92
Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors. Oncogene (2006) 0.91
Letter: Lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1975) 0.91
Significance and specificity of the Kveim reaction. Acta Med Scand Suppl (1964) 0.91
Immunologic diagnosis and monitoring of human acute leukemias: a review. Am J Pathol (1981) 0.90
Monocyte receptor activity in normal individuals and patients with sarcoidosis. Immunol Commun (1972) 0.90
An international Kveim test study. Acta Med Scand Suppl (1964) 0.89
Immunotherapy with dinitrochlorobenzene (DNCB) for recurrent squamous cell tumor of conjunctiva. Trans Am Ophthalmol Soc (1976) 0.89
Specific impairment of humoral and cellular allograft immunity after splenic allotransplantation in rats. Transplant Proc (1977) 0.88
Specificity of heteroantisera to human acute leukemia-associated antigens. J Clin Invest (1974) 0.87
Immunologic aberrations in the Di Guglielmo syndrome. Blood (1966) 0.87
Immunotherapy of human cancer. Prog Allergy (1973) 0.87
Random biopsy of bronchial and palatal mucosa in the diagnosis of sarcoidosis. Acta Med Scand Suppl (1964) 0.87
Induction of granulomas in mice by inoculation of tissue homogenates from patients with inflammatory bowel disease and sarcoidosis. Ann N Y Acad Sci (1976) 0.86
Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med Scand Suppl (1964) 0.86
Leukocyte migration agarose test (LMAT) in sarcoidosis using Kveim test material. Br J Dermatol (1978) 0.86
Isolation and partial characterization of radioiodinated myeloblastic leukemia-associated cell surface glycoprotein antigen. Cancer Res (1978) 0.85
Genetic analysis of adenovirus E1A: induction of genetic instability and altered cell morphologic and growth characteristics are segregatable functions. Mutat Res (1998) 0.85
Editorial: A transmissible agent in Crohn's disease? New pursuit of an old concept. N Engl J Med (1975) 0.84
Prolongation of skin homograft survival by mouse-anti-mouse thymocyte isoantiserum. Transplant Proc (1969) 0.84
Effects of heterologous antilymphocyte serum on lymphoid cells labeled with 5-iodo-2-deoxyuridine-125-I. Fed Proc (1970) 0.84
Characterization of compounds shed from the surface of human leukemic myeloblasts in vitro. Blood (1982) 0.84
Delayed cutaneous hypersensitivity in leukaemic patients to autologous blast cells. Br J Haematol (1974) 0.84
Cyclophosphamide-induced immunologic tolerance to skin homografts. Surg Forum (1971) 0.84
Flexible-bronchoscope biopsy of lung and bronchial wall in intrathoracic sarcoidosis. Ann N Y Acad Sci (1976) 0.84
Effects of corticosteroid therapy on kveim reactivity in sarcoidosis. Am Rev Respir Dis (1969) 0.83
Peripheral blood lymphocyte subpopulations in sarcoidosis. Cell Immunol (1975) 0.83
Serologic characterization of a monkey antiserum to human leukemic myeloblasts. Blood (1980) 0.83
Effects of pyrimidine antagonists on sialic acid regeneration in HL-60 cells. Cancer Res (1985) 0.83
Masking of neutrophil surface lectin-binding sites in chronic myelogenous leukemia (CML). Blood (1980) 0.83
Antigen-induced immunological tolerance in man to equine anti-human-thymocyte gamma-globulin. Lancet (1969) 0.82
Mechanisms and kinetics of cyclophosphamide-induced specific tolerance to skin allografts in mice. Transplant Proc (1973) 0.82
In vivo effects of concanavalin A. I. Immunosuppressive effects. Transplantation (1972) 0.81
Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies. Gut (1978) 0.81
Patterns of sarcoidosis in three population groups in New York City. Ann N Y Acad Sci (1976) 0.81
Effect of thymus enclosed in millipore diffusion envelopes on thymectomized hamsters. Blood (1966) 0.81
Effects of concanavalin A on the migration of radioactively labeled lymphoid cells. Cell Immunol (1974) 0.80
Angiotensin-I-converting enzyme and sarcoidosis. Ann Intern Med (1979) 0.80
Etiology of sarcoidosis. Practitioner (1969) 0.80
Changes in the granulocyte membrane following chemotherapy for chronic myelogenous leukaemia. Br J Haematol (1986) 0.80
Transpulmonary water exchange in newborn lambs under artificial placentation. Am J Physiol (1966) 0.80
Increased activity of a specific sialyltransferase in chronic myelogenous leukemia. Blood (1985) 0.79
Neurologic manifestations of sarcoidosis. Trans Am Neurol Assoc (1964) 0.79
Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ (1991) 0.79
Letter: B lymphocytes in inflammatory bowel disease. Lancet (1974) 0.79
Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials. Eur J Surg Oncol (2010) 0.79
Asymptomatic electrocardiographic alterations in sarcoidosis. Am Heart J (1973) 0.78
Phase II trial of the dopaminergic inhibitor pimozide in previously treated melanoma patients. Cancer Treat Rep (1983) 0.78
Platelets--cyclophosphamide-induced immunological tolerance to skin allografts in mice. Transplantation (1974) 0.78
The Kveim test in lepromatous and tuberculoid leprosy. Int J Lepr Other Mycobact Dis (1970) 0.78
Membrane glycoprotein changes associated with anthracycline resistance in HL-60 cells. Cancer Chemother Pharmacol (1991) 0.78
Monosaccharide inhibition of E-rosette formation. Clin Immunol Immunopathol (1980) 0.78
Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis. Cancer Res (1980) 0.77
Herpes-like virus and granulomatous colitis. Lancet (1970) 0.77
Production of antiserum in mice to human leukaemia-associated antigens. Nat New Biol (1973) 0.77